Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Haruyoshi Shirai is active.

Publication


Featured researches published by Haruyoshi Shirai.


Tetrahedron Letters | 1991

Structure of a novel phospholipase C inhibitor, vinaxanthone (Ro 09-1450), produced by penicillium vinaceum

Masahiro Aoki; Yoshiko Itezono; Haruyoshi Shirai; Noboru Nakayama; Akiko Sakai; Yutaka Tanaka; Akiko Yamaguchi; Nobuo Shimma; Kazuteru Yokose; Haruo Seto

Abstract Vinaxanthone is a novel phospholipase C inhibitor produced by Penicillium vinaceum Gilman and About NR6815. Its structre (MW 576, C28H16O14) has been elucidated as a polycyclic xanthone with poly acidic functional groups based on various NMR studies including HMBC, COLOC, 2D-INADEQUATE and selective 1D-INADEQUATE.


ACS Medicinal Chemistry Letters | 2013

Fluorine Scanning by Nonselective Fluorination: Enhancing Raf/MEK Inhibition while Keeping Physicochemical Properties

Ikumi Hyohdoh; Noriyuki Furuichi; Toshihiro Aoki; Yoshiko Itezono; Haruyoshi Shirai; Sawako Ozawa; Fumio Watanabe; Masayuki Matsushita; Masahiro Sakaitani; Pil-Su Ho; Kenji Takanashi; Naoki Harada; Yasushi Tomii; Kiyoshi Yoshinari; Kazutomo Ori; Mitsuyasu Tabo; Yuko Aoki; Nobuo Shimma; Hitoshi Iikura

A facile methodology effective in obtaining a set of compounds monofluorinated at various positions (fluorine scan) by chemical synthesis is reported. Direct and nonselective fluorination reactions of our lead compound 1a and key intermediate 2a worked efficiently to afford a total of six monofluorinated derivatives. All of the derivatives kept their physicochemical properties compared with the lead 1a and one of them had enhanced Raf/MEK inhibitory activity. Keeping physicochemical properties could be considered a benefit of monofluorinated derivatives compared with chlorinated derivatives, iodinated derivatives, methylated derivatives, etc. This key finding led to the identification of compound 14d, which had potent tumor growth inhibition in a xenograft model, excellent PK profiles in three animal species, and no critical toxicity.


The Journal of Antibiotics | 1975

A new antibiotic, fumaramidmycin. II. Isolation, structure and syntheses.

Yasuji Suhara; Hiromi B. Maruyama; Yoshiaki Kotoh; Yumiko Miyasaka; Kazuteru Yokose; Haruyoshi Shirai; Kouichi Takano


The Journal of Antibiotics | 1992

A new series of natural antifungals that inhibit P450 lanosterol C-14 demethylase. I. Taxonomy, fermentation, isolation and structural elucidation.

Shoko Matsukuma; Tatsuo Ohtsuka; Hiromichi Kotaki; Haruyoshi Shirai; Takashi Sano; Kimihiro Watanabe; Noboru Nakayama; Yoshiko Itezono; Morio Fujiu; Nobuo Shimma; Kazuteru Yokose; Toru Okuda


Archive | 1980

FLAVONE DERIVATIVES, THEIR PREPARATION, THESE NOVEL AND KNOWN FLAVONES AS ANTIVIRAL AGENTS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Hideo Ishitsuka; Haruyoshi Shirai; Isao Umeda; Yasuji Suhara


Archive | 1980

3-Alkoxyflavone antiviral agents

Hideo Ishitsuka; Haruyoshi Shirai; Isao Umeda; Yasuji Suhara


The Journal of Antibiotics | 1991

STRUCTURAL STUDIES ON AVIDINORUBICIN, A NOVEL ANTHRACYCLINE WITH PLATELET AGGREGATION INHIBITORY ACTIVITY

Masahiro Aoki; Haruyoshi Shirai; Noboru Nakayama; Yoshiko Itezono; Mitsuko Mori; Tomoko Satoh; Shoichi Ohshima; Junko Watanabe; Kazuteru Yokose; Haruo Seto


Chemical & Pharmaceutical Bulletin | 1980

Biochemically active substances from microorganisms. V. Pyrrothines, potent platelet aggregation inhibitors of microbial origin.

Yasuyuki Ninomiya; Yoosuke Yamada; Haruyoshi Shirai; Mitsuko Onitsuka; Yasuji Suhara; Hiromi B. Maruyama


Archive | 1997

Dibenzo-oxazepine and -dioxepine derivatives and their use as anti-tumor agents

Urvashi Hooda Dhingra; Haruyoshi Shirai; Yuki Takehana; Peter Michael Wovkulich; Nami Yabuki


Archive | 2001

DIBENZO-OXAZEPIN AND DIOXEPIN DERIVATIVES AND THEIR APPLICATION IN PRODUCTION OF MEDICAMENTS FOR TUMOUR TISSUES TREATMENT

Hooda Dhingra Urvashi; Haruyoshi Shirai; Yuki Takehana; Michael Wovkulich Peter; Nami Yabuki

Collaboration


Dive into the Haruyoshi Shirai's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge